Sex steroids levels in chronic kidney disease and kidney transplant recipients: associations with disease severity and prediction of mortality.
OBJECTIVE
Our objective was to characterize and evaluate prognostic implications of circulating sex steroids in patients at different stages of chronic kidney disease (CKD).


METHODS
Prospective observational cohort study.


METHODS
We prospectively recruited patients with CKD III-IV, undergoing chronic dialysis and kidney transplant recipients (KTR) from a single centre in 2003-2004.


METHODS
Two stored samples taken 3 months apart were analysed for sex hormones using liquid chromatography/tandem mass spectrometry, and the mean of the two was used for analysis. We also measured novel biomarkers troponin T and NT-proBNP. Patients were followed until death, transplant or 30 June 2013, and survival analysis performed.


RESULTS
In males, but not in females, both testosterone (P = 0·003) as well as oestradiol (P < 0·02) levels were lowest in dialysis patients and highest in KTR. Over a median follow up of 8·5 years (interquartile range 3·8-9·2), 52 men (36%) died and 24 (17%) received a kidney transplant. In Cox proportional hazards regression up to 9·6 years, an increase in total testosterone of 1 nmol/l was associated with a 9·8% (95% confidence interval 3·1-16·3) decrease in mortality independent of age, body mass index, stage of renal disease and circulating levels of NT-proBNP or troponin T. By contrast, sex steroid levels were not associated with mortality in females.


CONCLUSIONS
Testosterone levels differ across stages of kidney disease and low testosterone levels predict mortality in males, independent of established and novel predictors of mortality.
Department of Medicine Austin Health, University of Melbourne, Heidelberg, Vic., Australia; Endocrine Unit, Austin Health, Heidelberg, Vic., Australia.
Mathis
M
Grossmann
Rudolf
R
Hoermann
Mark
M
Ng Tang Fui
Jeffrey D
JD
Zajac
Franscesco L
FL
Ierino
Matthew A
MA
Roberts
D000328:Adult; D000368:Aged; D015992:Body Mass Index; D004958:Estradiol / Q000097:blood; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D011446:Prospective Studies; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D012737:Sex Factors; D053719:Tandem Mass Spectrometry; D013739:Testosterone / Q000097:blood; D016896:Treatment Outcome
D012739:Gonadal Steroid Hormones; D013739:Testosterone; D004958:Estradiol